These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25410660)

  • 1. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.
    Moujalled D; James JL; Yang S; Zhang K; Duncan C; Moujalled DM; Parker SJ; Caragounis A; Lidgerwood G; Turner BJ; Atkin JD; Grubman A; Liddell JR; Proepper C; Boeckers TM; Kanninen KM; Blair I; Crouch PJ; White AR
    Hum Mol Genet; 2015 Mar; 24(6):1655-69. PubMed ID: 25410660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress.
    Moujalled D; James JL; Parker SJ; Lidgerwood GE; Duncan C; Meyerowitz J; Nonaka T; Hasegawa M; Kanninen KM; Grubman A; Liddell JR; Crouch PJ; White AR
    PLoS One; 2013; 8(6):e67433. PubMed ID: 23840699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway.
    Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ; Prudencio M; Petrucelli L; Blair I; Ittner LM; Crouch PJ; Liddell JR; White AR
    Hum Mol Genet; 2017 May; 26(9):1732-1746. PubMed ID: 28334913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
    Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
    Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing.
    Bampton A; Gatt A; Humphrey J; Cappelli S; Bhattacharya D; Foti S; Brown AL; Asi Y; Low YH; Foiani M; Raj T; Buratti E; Fratta P; Lashley T
    Acta Neuropathol; 2021 Oct; 142(4):609-627. PubMed ID: 34274995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar Degeneration.
    Kattuah W; Rogelj B; King A; Shaw CE; Hortobágyi T; Troakes C
    Front Neurosci; 2019; 13():551. PubMed ID: 31213972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of native and phosphorylated TDP-43 immunoreactivity by proteinase K treatment following autoclave heating.
    Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2011 Aug; 31(4):401-4. PubMed ID: 21175864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurodegenerative disorders and TDP-43].
    Nonaka T; Inukai Y; Arai T; Hasegawa M
    Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins.
    Duan Y; Du A; Gu J; Duan G; Wang C; Gui X; Ma Z; Qian B; Deng X; Zhang K; Sun L; Tian K; Zhang Y; Jiang H; Liu C; Fang Y
    Cell Res; 2019 Mar; 29(3):233-247. PubMed ID: 30728452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.
    Walker AK; Soo KY; Sundaramoorthy V; Parakh S; Ma Y; Farg MA; Wallace RH; Crouch PJ; Turner BJ; Horne MK; Atkin JD
    PLoS One; 2013; 8(11):e81170. PubMed ID: 24312274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: evidence for loss of TDP-43 nuclear function.
    Orrù S; Coni P; Floris A; Littera R; Carcassi C; Sogos V; Brancia C
    Hum Mol Genet; 2016 Oct; 25(20):4473-4483. PubMed ID: 28172957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
    Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropathology of TDP-43 proteinopathy].
    Akiyama H; Hasegawa M
    Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Component of ubiquitin-positive inclusions in ALS].
    Hasegawa M; Arai T
    Brain Nerve; 2007 Oct; 59(10):1171-7. PubMed ID: 17969358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
    Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.